ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 580,03
-0,69%
Dow Jones
40 844,72
1,57%
DAX
18 518,03
-0,44%
Brent Oil
83,335
-1,19%
Bitcoin
64 321,06
-0,81%
Registration Strip Icon for default Inscrivez-vous gratuitement pour obtenir des cotations en temps réel, des graphiques interactifs, un flux d'options en direct et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NYSE
  6. Teva Pharmaceutical Industries Ltd (TEVA)

  7. Teva Pharmaceutical Industries Ltd (TEVA) Actualités

TEVA

Teva Pharmaceutical Indu... (TEVA)

Teva Pharmaceutical Industries Ltd
De:
Trier par:
 Showing the most relevant articles for your search:NYSE:TEVA
DateHeureSourceTitreSymboleSociété
24/03/201521h41Business WireTeva Announces Pricing of €2 Billion of Senior NotesNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201514h59Dow Jones NewsTeva Migraine Therapy Shows Positive Results in Phase IIb StudyNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201514h14Edgar (US Regulatory)Report of Foreign Issuer (6-k)NYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201514h00Business WireTeva Announces New Head of Business Development, Strategy and InnovationNYSE:TEVATeva Pharmaceutical Industries Ltd
23/03/201513h46Business WireTeva’s TEV-48125 Meets Primary & Secondary Endpoints in Episodic Migraine Study, Demonstrating Treatment Concept After a Si...NYSE:TEVATeva Pharmaceutical Industries Ltd
17/03/201521h00Business WireTeva and Ignyta Announce Acquisition by Ignyta of Four Oncology R&D Assets from TevaNYSE:TEVATeva Pharmaceutical Industries Ltd
12/03/201521h00GlobeNewswire Inc.Xenon Pharmaceuticals Reports 2014 Financial Results and Provides Corporate UpdateNYSE:TEVATeva Pharmaceutical Industries Ltd
05/03/201515h01Business WireTeva to Present at the Barclays Global Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201523h29Dow Jones NewsMylan Posts Higher Profit and SalesNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201515h50Dow Jones NewsCorrection to Story About Teva Selling Pennsylvania FacilityNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201515h18Dow Jones NewsTeva Sells Pennsylvania Facility to G&W LaboratoriesNYSE:TEVATeva Pharmaceutical Industries Ltd
02/03/201514h22Business WireTeva Announces Sale of Sellersville, PA FacilityNYSE:TEVATeva Pharmaceutical Industries Ltd
27/02/201514h30Business WireTeva Announces Early Results of Debt Tender Offer, Pricing, Election of Early Settlement & Increase in Maximum Amount & Prior...NYSE:TEVATeva Pharmaceutical Industries Ltd
26/02/201514h00Business WireTeva to Present at the Cowen & Company 35th Annual Healthcare ConferenceNYSE:TEVATeva Pharmaceutical Industries Ltd
25/02/201514h00Business WireTeva Announces FDA Acceptance for Review of NDA for its Investigational Twice-Daily Hydrocodone Bitartrate Extended-Release T...NYSE:TEVATeva Pharmaceutical Industries Ltd
24/02/201515h00Business WireTeva Announces Positive Results for TEV-48125 in Phase IIb Chronic Migraine Study Meeting Primary and Secondary EndpointsNYSE:TEVATeva Pharmaceutical Industries Ltd
23/02/201521h00Business WireThe Lancet Respiratory Medicine & AAAAI Publish Positive Data from Phase III Trials of Teva’s Reslizumab for the Treatment ...NYSE:TEVATeva Pharmaceutical Industries Ltd
20/02/201514h00Business WireTeva to Present New Respiratory Data at 2015 Annual Meeting of the American Academy of Allergy, Asthma and ImmunologyNYSE:TEVATeva Pharmaceutical Industries Ltd
18/02/201500h36Dow Jones NewsADR Shares End Higher; Chinese Oil Majors' Shares RiseNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201523h30Business WireLaw Firm Kirby McInerney LLP Investigating Potential Claims on Behalf of Teva Pharmaceutical Industries Ltd. StockholdersNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201514h33Dow Jones NewsTeva to Distribute Eagle Pharmaceutical's Cancer Drug in U.S.NYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201514h30Business WireTeva Bolsters Injectable Portfolio with Launch of Generic Lovenox® and Generic Zyvox® in the United StatesNYSE:TEVATeva Pharmaceutical Industries Ltd
17/02/201513h00Business WireTeva and Eagle Pharmaceuticals Announce Teva’s License to Commercialize Eagle’s Bendamustine Rapid Infusion ProductNYSE:TEVATeva Pharmaceutical Industries Ltd
13/02/201519h59Edgar (US Regulatory)Amended Statement of Ownership (sc 13g/a)NYSE:TEVATeva Pharmaceutical Industries Ltd
12/02/201514h26Business WireTeva Announces $1 Billion Debt Tender OfferNYSE:TEVATeva Pharmaceutical Industries Ltd
10/02/201508h51Business WireTeva Files 2014 Annual Report on Form 20-FNYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201522h29Edgar (US Regulatory)Automatic Shelf Registration Statement of Securities of Well-known Seasoned Issuers (f-3asr)NYSE:TEVATeva Pharmaceutical Industries Ltd
09/02/201522h10Edgar (US Regulatory)Annual and Transition Report (foreign Private Issuer) (20-f)NYSE:TEVATeva Pharmaceutical Industries Ltd
06/02/201500h01Dow Jones NewsADR Shares End Higher; Tata Motors Shares FallNYSE:TEVATeva Pharmaceutical Industries Ltd
05/02/201513h00Business WireTeva Reports Fourth Quarter and Full Year 2014 ResultsNYSE:TEVATeva Pharmaceutical Industries Ltd
 Showing the most relevant articles for your search:NYSE:TEVA

Dernières Valeurs Consultées

EU
CS
Axa
NYSE
MCD
McDonalds
USI
USTECH100
US Tech 100
NASDAQ
GOOGL
Alphabet
EU
MC
Lvmh Moet Hennessy Louis...
FTSE
UKX
FTSE 100
NYSE
NKE
Nike
EU
LR
Legrand
NYSE
DIS
Walt Disney
EU
BEL20
Bel 20
EU
ORA
Orange
EU
RI
Pernod Ricard
COIN
ETHUSD
Ethereum
NYSE
MRK
Merck
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés